These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 16448390

  • 1. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human.
    Cheng J.
    Fundam Clin Pharmacol; 2006 Feb; 20(1):1-8. PubMed ID: 16448390
    [Abstract] [Full Text] [Related]

  • 2. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP.
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [Abstract] [Full Text] [Related]

  • 3. Drugs for men and women - how important is gender as a risk factor for TdP?
    Coker SJ.
    Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
    [Abstract] [Full Text] [Related]

  • 4. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
    Wolbrette D.
    Curr Womens Health Rep; 2002 Apr; 2(2):105-9. PubMed ID: 12116598
    [Abstract] [Full Text] [Related]

  • 5. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, Mönnig G, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
    [Abstract] [Full Text] [Related]

  • 6. Recent advances in understanding sex differences in cardiac repolarization.
    James AF, Choisy SC, Hancox JC.
    Prog Biophys Mol Biol; 2007 Jul; 94(3):265-319. PubMed ID: 15979693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
    Jonsson MK, Vos MA, Duker G, Demolombe S, van Veen TA.
    Pharmacol Ther; 2010 Jul; 127(1):9-18. PubMed ID: 20462510
    [Abstract] [Full Text] [Related]

  • 9. Gender-related differences of ventricular repolarization in LQT2 rabbit model.
    Liu LP, Yang L, Zhao Z, Chen Q.
    Sheng Li Xue Bao; 2005 Dec 25; 57(6):749-54. PubMed ID: 16344901
    [Abstract] [Full Text] [Related]

  • 10. Gender-related differences in ventricular myocyte repolarization in the guinea pig.
    James AF, Arberry LA, Hancox JC.
    Basic Res Cardiol; 2004 May 25; 99(3):183-92. PubMed ID: 15088103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A, Sugiyama A, Hashimoto K.
    Br J Pharmacol; 2005 Oct 25; 146(4):561-7. PubMed ID: 16056235
    [Abstract] [Full Text] [Related]

  • 13. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P, Reinsch N, Osada N, Wasmer K, Mönnig G, Stypmann J, Breithardt G, Haverkamp W, Eckardt L.
    Basic Res Cardiol; 2005 Jul 25; 100(4):365-71. PubMed ID: 15944809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gender differences in autonomic modulation of ventricular repolarization in humans.
    Nakagawa M, Ooie T, Ou B, Ichinose M, Takahashi N, Hara M, Yonemochi H, Saikawa T.
    J Cardiovasc Electrophysiol; 2005 Mar 25; 16(3):278-84. PubMed ID: 15817086
    [Abstract] [Full Text] [Related]

  • 16. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
    Milberg P, Reinsch N, Wasmer K, Mönnig G, Stypmann J, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    Cardiovasc Res; 2005 Feb 01; 65(2):397-404. PubMed ID: 15639478
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ, Roden DM.
    Curr Opin Cardiol; 2007 Jan 01; 22(1):39-43. PubMed ID: 17143043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Torsades, sex hormones, and ventricular repolarization.
    Ciaccio EJ.
    J Cardiovasc Electrophysiol; 2011 Mar 01; 22(3):332-3. PubMed ID: 21040096
    [No Abstract] [Full Text] [Related]

  • 20. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W.
    J Clin Pharmacol; 2009 Jan 01; 49(1):6-16. PubMed ID: 18957528
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.